FibroBiologics, Inc. Common Stock
General ticker "FBLG" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $429.7M (TTM average)
FibroBiologics, Inc. Common Stock does not follow the US Stock Market performance with the rate: -36.8%.
Estimated limits based on current volatility of 3.5%: low 1.00$, high 1.08$
Factors to consider:
- Total employees count: 13 as of 2024
- Current price 92.0% below estimated low
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [18.07$, 60.55$]
- 2025-12-31 to 2026-12-31 estimated range: [13.06$, 42.35$]
Short-term FBLG quotes
Long-term FBLG plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $4.47MM | $8.89MM | $13.74MM |
| Operating Income | $-4.47MM | $-8.89MM | $-13.74MM |
| Non-Operating Income | $-0.65MM | $-7.60MM | $2.58MM |
| Interest Expense | $0.65MM | $0.15MM | $0.02MM |
| R&D Expense | $1.15MM | $2.37MM | $4.50MM |
| Income(Loss) | $-5.12MM | $-16.48MM | $-11.16MM |
| Profit(Loss)* | $-5.12MM | $-16.48MM | $-11.16MM |
| Stockholders Equity | $-4.00MM | $1.25MM | $2.73MM |
| Assets | $4.82MM | $11.82MM | $16.45MM |
| Operating Cash Flow | $-4.07MM | $-6.40MM | $-11.90MM |
| Capital expenditure | $0.00MM | $0.49MM | $0.18MM |
| Investing Cash Flow | $0.00MM | $-0.49MM | $-0.18MM |
| Financing Cash Flow | $5.92MM | $13.79MM | $16.91MM |
| Earnings Per Share** | $-3.15 | $-10.15 | $-6.79 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.